end image for the medical devices navigation bar, decorative only
close popup
  ObjectiveApproachMarketsProductsDevicesHumanitarianCommitmentCultureRegulatory  

OUR OBJECTIVE

To develop cutting edge medical technology that improves the livelihood and quality of health care to patients while optimizing efficiency and safety for clinicians.

OUR APPROACH

EMED works with clinicians, inventors and medical companies to develop innovative medical products.

We believe in continuous product improvement and open discussion forums to encourage inquiries and suggestions regarding new or existing products.

MARKETS WE SERVE

We specialize in the following markets: Hospitals, Home health care, Hospice, Surgery Centers, Pharmacies, Home Infusion, and Anesthesia. (Read more...)

OUR PRODUCTS

We offer superior products for the following specialties: Diabetes, Oncology, IV Therapy, Sub-Q Therapy, Implanted Port Therapy, Bowel Incontinence, Urinary Incontinence, Surgical Accessories and Endoscope Cleaning Devices. (Read more...)

SPECIAL DEVICES

Clinicians often times need devices that improve upon the features and benefits of conventional alternatives.

EMED offers a wide variety of technology platforms that can be enhanced according to specific protocols. (Read more...)

HUMANITARIAN

EMED has outlined ambitious goals relative to its ability to make accessible its products to patients in developing countries where resources are limited.

To this effect, EMED has initiated a program that coordinates medical product donations through charitable organizations. EMED will continue to enhance its involvement in the promotion of this and other programs. We promote donations of companies that share our goals.

EMED has allocated a budget to match third party donations for patients that cannot afford a specific therapy. (Read more...)

OUR COMMITMENT

We are privileged to work in an industry where the work we do enhances the quality of healthcare.

Product quality is paramount as is ensuring the safety and efficacy of our products.

We are committed to the highest quality standards attainable to protect the health and safety of patients.

EMED considers part of its responsibility to provide sound information and a forum for clinical dialog with patients and clinicians who use our products.

You can contact EMED by sending an inquiry to: info@emedtc.com

OUR CORPORATE CULTURE

EMED's approach includes focusing on developing medical devices that improve patient's lives.

We believe sustainability should encompass all levels of our organization including not only our products but the quality of our management, the opportunities we offer all members of our team.

We are committed to developing medical products that are based on Patient's needs and Clinical Research to optimize features and benefits of our devices. (Read more...)

QUALITY, REGULATION & ISO 13485 CERTIFICATION

EMED Technologies Corporation is ISO 13485 Certified

EMED Technologies CE Marks may be reviewed here CE Marks

EMED's products, facilities and operations are subject to regulation by the U.S. Food and Drug Administration (FDA) and other regulatory authorities worldwide.

EMED works with such authorities to develop and manufacture safe and effective products for its customers. (Read more...)

 
close popup
 

News & Events

 

    Scroll down to see all news items...

  • July 2015
    EMED receives Therapeutic Goods Administration (TGA) approval to supply the SCIg60 Infusion System and SUB-Q subcutaneous administration sets to the Australian market…
     

  • May 2015
    EMED receives 510k market clearance for the SCIg60 Infusion System, intended for infusion of Hizentra® Immune Globulin Subcutaneous (Human) 20% Liquid … read more
     

  • September 2014
    EMED obtains Brazilian ANVISA registration of the detruset® intravesical electrical stimulation catheter…
     

  • May 2014
    EMED receives 510k market clearance for Infuset flow control extension sets…
     

  • February 2014
    EMED transitions to EMERGO Group, a leading international consultancy, as its European Authorized Representative for medical device sales to the EU…
     

  • January 2013
    EMED receives 510k market clearance for VersaRate ® variable flow rate controller set…
     

  • Oct 2012
    EMED Technologies Corporation today announced successful Noridian coding verification of its SCIg60 Infusion System…read more
     

  • May 2012
    EMED announces CE Mark and Canadian Medical Device License Approval…read more
    EMED announces the launch of Soft-GlideTM SUB-Q Infusion Sets…read more
     

  • Oct 2009
    EMED anticipates opening its European headquarters in Ireland…
     

  • March 2008
    EMED Technologies acquires Evans Medical Inc…
     

  • September 2007
    EMED Technologies Corporation announces the acquisition of Innovamed USA… ...read more ...
     

  • June 2007
    Established emedicaldevices.com as a division to focus on Licensing and Intellectual Property
     

  • March 2005
    EMED Technologies launches its SUB-Q administration line of products…
     

  • June 2004,
    EMED Technologies moves its headquarters to Northen California…